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Abstract 
Aims: Current attempts to modulate the human microbiota and immune responses are based 
on probiotics or human-derived bacterial transplants. We investigated microbial modulation 
by soil and plant based material. Materials & Methods: We performed a pilot study in which 
healthy adults were exposed to the varied microbial community of a soil and plant based 
material. Results: The method was safe and feasible, exposure was associated with an 
increase in gut microbial diversity. Conclusions: If these findings are reproduced in larger 
studies nature-derived microbial exposure strategies could be further developed for testing 
their efficacy in the treatment and prevention of immune-mediated diseases. 
Introduction 
An urban lifestyle and reduced exposure to diverse environmental microbes may disturb the 
development of immunoregulatory mechanisms and contribute to incidence of immune-
mediated diseases which has increased globally[1,2]. These suggested connections are 
supported by ecological studies showing differences in the diversity, abundance and 
composition of skin and gut microbiota of people living either in urban or rural areas[2]. 
Accordingly, many immune-mediated diseases are characterized by gut microbiome dysbiosis 
associated with an urban lifestyle[3]. All previously published intervention trials aiming at 
changing the human microbiota have been based on the use of only a single or a few bacteria 
(probiotics)[4,5] or fecal and vaginal microbiome transplantations[6,7]. Exposure to few fast-
growing probiotics is strikingly different from the microbiota of natural soils characterized by 
high bacterial diversity and the predominance of dormant and slowly growing bacteria[8,9] 
that have become rare in urban environments. Here, we introduce a novel strategy for 
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modulating the human microbiome and immune system using a nature-derived diverse 
microbiome including non-culturable and slowly growing bacteria. 
Materials and methods 
Study groups, exposure and sampling 
Fourteen volunteers living in urban settings (healthy adults, age 27-63 years) participated in 
the safety and feasibility -oriented open trial using a case-control design. The medical 
exclusion criteria were the following: immune deficiencies, immunosuppressive medications, 
3 or more infections within a year that required hospitalization, condition affecting the 
immune response (e.g. rheumatoid arthritis, colitis ulcerosa, Crohn’s disease), memory 
disorder diagnosed by a medical doctor, acute depression or acute or earlier psychosis, cancer 
diagnosis within the last two years or on-going cancer treatment, type 1 or type 2 diabetes, 
rash or ulcers in hands. Other exclusion criteria included: living outside city area, age under 
18 or over 65, incompetency and daily smoking.  All participants provided a written, informed 
consent. General immunological health status and protection against Clostridium tetani was 
confirmed before starting the experiment by analyzing complete blood count (CBC), 
differential blood count and serum Clostridium tetani tetanus toxoid antibodies from all study 
subjects in a certified hospital laboratory (Fimlab laboratories, Tampere, Finland).  All subjects 
having a deviation from reference values in any of the analyzed were excluded from the study. 
A study nurse checked that the skin on the participants’ hands was in good condition having 
no eczema or wounds before starting the trial. Approval to conduct the research was obtained 
from the ethical committee of the local hospital district (Pirkanmaa Hospital District, Finland). 
The study was conducted in accordance with the principle of the Helsinki Declaration. The 
trial has been registered in ClinicalTrials.gov (ID NCT03351543). 
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The study subjects were divided into two groups which were similar in their gender, age, pet 
ownership, and dwelling type (apartment building, row house, detached house) distribution. 
One group followed the exposure protocol while the other was a non-exposed control group. 
The median age was 36 years (range 27-57 years) in the intervention group and 28.6% were 
males. Corresponding figures in the control group were 42 years (range 28-63 years) and 
28.6%. 
The exposure group conducted a two-week long exposure by rubbing their hands with a soil 
and plant based immunomodulatory composition three times per day: before breakfast, 
before dinner/evening snack, and before going to bed. The participants were instructed to 
rub the material into their hands for 20 seconds after which they washed their hands with tap 
water but without soap for five seconds and dab their hands dry with a towel. The material 
aliquot was replaced with a new aliquot in the middle of the exposure period. 
The soil and plant based composition was manufactured by sieving and combining various 
composted Finnish soil and plant materials in the laboratory of environmental ecology, 
University of Helsinki. The general ingredients for these soil types were various compositions 
of industrial composts originating from raw materials such as cattle dung, horse dung, chicken 
dung, deciduous leaf litter, plant debris, horticultural peat, sludge, fine mineral soil such as 
silt as well as crushed tree bark mulch. Each major ingredient was sieved using a Ø 5 mm sieve 
and each minor ingredient using a Ø 2 mm sieve. Moss was dried, crushed and mixed 
thoroughly before mixing with other ingredients. Major ingredients, moss and minor 
ingredients were used so that eight parts of each major ingredient, two parts of moss and one 
part of each minor ingredient was mixed thoroughly. Figure 2c. contains the phylum 
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operational taxonomy metrics, as detected using 16s rRNA sequencing of the soil and plant 
composition matter microbial composition. 
The participants collected stool samples and skin swab samples from 5x5 cm area of the volar 
surface of the forearm at home right before the exposure period (day 0), immediately after 
the exposure period (day 14), and three weeks after the exposure period (day 35) and stored 
the samples in a freezer until they had a study nurse visit few days later. The nurse collected 
blood samples and interviewed the subjects on each visit about their health status during the 
study period. In addition, adherence to the exposure protocol, adverse effects and potential 
life-style changes during the exposure period (e.g. nutrition, dietary supplements and 
medications) were recorded after the exposure period. 
The bacterial 16S rDNA amplicon profiling 
The total DNA was extracted from 30-60 mg of frozen unprocessed stool, or from skin swabs 
frozen in sterile swab solution (0.15 M NaCl, 0.1% Tween), both using PowerSoil® DNA 
Isolation Kit (formerly MoBio, now Qiagen, Hilden, Germany) according to the manufacturer’s 
standard protocol. To establish the bacteriome profiles of samples, we used mass amplicon 
sequencing of the V4 region of 16S rDNA. The primers sequences targeting this region were 
identical to 515F and 806R primers described elsewhere[10]. After the amplicons tailed with 
sequencing adaptors had been generated, we purified them with Agencourt AMPure 
(Beckman), equalized their concentration, pooled and sequenced on a MiSeq instrument 
(Illumina). For compatibility with earlier projects using the same sample types, the pipelines 
of amplicon creation slightly differed between stool samples and skin samples; it has to be 
noted that the target region and primers were exactly identical, and so was the amplicon 
position in the V4 alignment. The stool samples were amplified using a grid of primers already 
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synthesized with pad, linker, index and sequencing adaptors whereas the skin samples were 
first amplified with simple primers, and only then the amplicons were provisioned with the 
indices using a tag PCR, and with sequence adaptors using a ligation step. To control the 
process, Mock Community, which is a complex mix of bacterial DNA of a known content 
(courtesy of BEI Resources, please see Acknowledgements), a positive control (Enterococcus 
faecalis), and negative controls (water instead of sample) were utilized throughout the 
sequencing. 
Sequence processing 
Next-generation sequencing data from skin and stool were processed and analyzed using 
mothur (version 1.36.1)[11], custom python scripts, and QIIME[12]. The sequence 
processing protocol partly followed the pipeline suggested earlier[13,14]. The paired 
sequences contained in reverse and forward fastq files were aligned into contigs. Sequences 
were trimmed and screened to remove any mismatches with primer or DNA-tag sequences, 
ambiguous bases and homopolymers larger than 8 bp long. Sequences were aligned using 
mothur version of SILVA bacterial reference sequences (version 102)[15] and the sequences 
which were not aligned to a reference alignment of the correct sequencing region were 
removed. Unique sequences and their frequency in each sample were identified and 
screened for chimeras (usearch academic version, http://www.drive5.com/usearch for 
stools, UCHIME[16] for skin and exposure material samples) using the abundant sequences 
as a reference. The chimeric sequences were removed. We calculated a pairwise distance 
matrix for unique sequences and clustered OTUs at 97% sequence similarity using the 
nearest neighbor algorithms. Sequences were classified using the Mothur version of 
Bayesian classifier[17] with the RDP training set version 9[18]. Sequences classified to 
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Chloroplast, Mitochondria, unknown, Archaea and Eukaryota were removed from the 
analyses. Green genes[19] core imputed reference was further integrated for building 
phylogenetic tree required for further downstream statistical analysis. The exposure 
material from soil and plant composition were also processed using mothur and SILVA 
bacterial reference. While stool, skin and exposure material samples were sequenced in 
different batches, we aggregated OTUs up to phylum to be able to compare different 
sample types. 
Blood samples 
Blood samples were taken into Vacutainer® CPT™ Mononuclear Cell Preparation tubes with 
sodium citrate (BD Biosciences, USA) and centrifuged according to manufacturer’s 
instructions. The peripheral blood mononuclear cells (PBMCs) were snap frozen in liquid 
nitrogen and stored at -80°C. 
Real-time qPCR 
Cytokine mRNA expression in snap frozen PBMCs was measured using real-time qPCR. The 
RNA was extracted using RNeasy Mini Kit (Qiagen, Hilden, Germany) following the 
manufacturer's instructions and reversely transcribed into cDNA with oligo-dT and random 
hexamer primers using Promega M-MLV Reverse Transcriptase reagents (Promega, Madison, 
WI, USA). Primers for IL-10 (interleukin 10), TGF-b (transforming growth factor beta) and TBP 
(TATA-box binding protein, a housekeeping gene) were: forward: 5’-CAG TTT TAC CTG GAG 
GAG GTG-3’, reverse: 5’-AGA TGC CTT TCT CTT GGA GCT TAT-3’, forward: 5’-ACG TGG AGC 
TGT ACC AGA AAT AC-3’, reverse: 5’-GTA GTG AAC CCG TTG ATG TCC-3’, forward: 5’-CGA ATA 
TAA TCC CAA GCG GTT-3’ and reverse: 5’-ACT TCA CAT CAC AGC TCC CC-3’, respectively. The 
qPCR reaction mixture was prepared using DyNAmo Flash SYBR Green qPCR Kit (Thermo 
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Fisher Scientific, Waltham, MA, USA) and ABI Prism® 7900 HT (Applied Biosystems) apparatus 
according to the manufacturer’s instructions. Gene expression values were normalized to the 
amount of TBP using previously described method[20]. 
Statistical methods 
The R language platform was used for data integration and plotting. Key packages include the 
microbial packages phyloseq V16.2[21]and vegan[22] along with fold change estimation 
Deseq2[23]. The purpose of the statistical analyses was to find out whether the exposure led 
to shifts in bacterial diversity in fecal and skin samples and if the changes were associated 
with the differences in cytokine mRNA expression. Linear regression analysis was performed 
in IBM SPSS ver 24.0. 
Differences in bacterial diversity between the exposed and controls were analyzed using 
Shannon diversity index as well as visually via relative phylum abundance plots over time 
periods in match group panels. Changes and rates of change between the start and the end 
of the exposure were especially important, as the composition change would provide directly 
comparable results to the exposure effects on gut and skin microbiome. Samples were 
subsampled to the minimum number of reads per sample to filter rare OTUs to preserve 
maximal bacterial diversity representation and to account for varying sample size when 
comparing diversity. All samples within the exposed and controls passed this threshold. The 
difference between bacterial composition in the samples before and after exposure was 
calculated using rate of change in Shannon diversity index between days 0 and 14. 
Rate of change of Shannon diversity index was tested using two-sided non-paired T-test and 
normal distribution was confirmed with a QQ-Plot (Supplementary Fig. 2). Phyloseq together 
with ggplot2[24] was used for relative abundance plotting. 
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NCBI: sequence data have been deposited under study accession number PRJNA390051. 
Results 
Study population and exposure 
We conducted an open pilot trial among 14 healthy adultsto evaluate the feasibility and safety 
of this exposure and to study whether it can modulate the skin and gut microbiome or the 
immune system. The exposure material included 861 OTUs (≥97% similarity) from 19 phyla 
based on 16S rRNA sequencing (Fig. 2c; the two most abundant phyla being Bacteroidetes 
and Proteobacteria).  No changes in the microbial composition of the material were seen 
when the material was analyzed after it was used in the exposure. 
The exposure was performed thrice a day for two weeks with high compliance (Fig 1b, 
Supplementary Table 1). Overall, the procedure was feasible and safe; minor inconveniences 
were messiness of the material (reported by 71% of participants), dirt under the nails and 
coloring (57%) and drying of the hands (43%) during the trial. No clinically relevant adverse 
effects (abrasions, cuts, ulcers, rash or other skin symptoms) were recorded. 
Microbiota composition and diversity 
Skin swabs, stool and blood samples were collected in order to study the possible changes in 
the microbiome (Fig. 1a). Sequencing of the bacterial 16S rRNA[14] showed that the alpha 
diversity of the stool microbiome increased during the exposure compared to controls 
(p=0.029; Fig. 2b and Supplementary Fig. 2). The change seemed to be coupled with an 
increase in of the abundance of phyla Bacteroides. This increase was not seen in the control 
group (Supplementary Fig. 1.) There were no difference between the groups in alpha diversity 
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before the exposure or three weeks after the exposure. In addition, the alpha diversity of the 
skin microbiome increased clearly in two individuals (red dots Fig. 2b) but the overall change 
was not significant.  These two individuals experienced a stronger exposure than others in the 
intervention group; their hands were clearly colored after exposure as they washed their 
hands superficially and did not rub their hands dry with a towel afterwards (Supplementary 
Table 1). Furthermore, the microbial composition of the skin of these two individuals showed 
an increase of the phyla Bacteroidetes, Chlorflexi and Actinobacteria, which were abundant 
in the exposure material (Fig 2a and 2c.) although the phylum changes were not dramatic. 
Association of microbial diversity change to immune system markers 
Next, we compared the change in bacterial diversity in the exposure group to the expression 
of two immunoregulatory cytokines (TGF-beta and IL-10 mRNA) in peripheral blood 
mononuclear cells (PBMCs) at the end of the exposure period.  The change in the bacterial 
diversity in both the skin and stool was associated with the level of TGF-beta expression right 
after the exposure period (R2 = 0.971, p = 0.001, Supplementary Fig. 3). However, bacterial 
diversity change did not correlate with IL-10 expression. 
Discussion 
The present trial is the first study in which a rich nature-derived preparation of diverse 
microbial composition is administered to humans in the form of a validated and processed 
nature-based material. The results suggest that even a short two-week exposure to this 
material can modulate the microbiome in urban dwellers whose contacts with 
microbiologically diverse and rich environments are otherwise limited. The change in the 
stool microbiome during the exposure implies that the exposure can modulate the 
microbiome relatively widely. Our previous studies indicate that this treatment clearly 
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changes skin microbiome at the exposure site (Gronroos et al., unpublished observations). 
The present study suggests that this change can also spread to more distant skin areas when 
the local exposure has been intense enough: the two participants whose palm exposure was 
particularly intense had a clear change in skin diversity in the forearm skin. This could also be 
achieved by developing the application method.The potential of the tested exposure 
procedure is emphasized by the fact that previous trials using orally administered probiotic 
bacteria have not been able to demonstrate a clear change in the gut microbiome of healthy 
adults [5,25]. 
Conclusions 
Altogether, the results of this pilot study give reason to carry out larger,long-term, 
randomized, placebo-controlled and blinded trials to validate these findings and to evaluate 
the effects of this intervention on the immune system. More studies would also be needed to 
identify optimal application methods and delivery regimens. Provided the current findings are 
reproduced in larger studies, nature-derived microbial exposure strategies could be further 
developed for trials testing their efficacy in the treatment and prevention of immune-
mediated diseases. 
Future Perspective 
The understanding of the role human microbiome for the health is increasing rapidly. It is 
therefore likely that the modulation of microbiome becomes an important part of patient 
care as demonstrated by the success of fecal transplantations in restoring the healthy gut 
microbiome. In the future, the aims are to standardize the treatment regimens and tailor 
them for individual purposes. The long-term goal includes also the prevention of diseases, 
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which introduces new challenges in terms of scalability and safety of these treatments. 
Prevention of immune-mediated diseases is a highly attractive target, as these diseases are 
increasing rapidly and affect a large proportion of population. The means used for the 
induction of beneficial immunological effects by microbial exposures should not be limited 
to the modulation of colonizing microbiome but cover also the stimulation of the immune 
system vial multiple routes using a wide range of microbe-associated molecular patterns. 
The currently described new regime, a daily exposure to the microbial diversity that is 
present in the nature, may offer one feasible way to introduce beneficial immunological 
effects to a large group of people in a safe way. 
Summary points 
 Many immune-mediated diseases are characterized by gut microbiome dysbiosis
associated with an urban lifestyle. This has led to e.g. clinical probiotic intervention 
studies trying to modulate the microbiome diversity but these studies have lacked a 
demonstration of a clear change in the gut microbiome of healthy adults. 
 We investigated gut and skin microbial modulation with soil and plant based material
containing diverse microbial composition including also slowly growing bacteria lacking 
from probiotic interventions. 
 We show that the method is a safe and feasible way of modulating the microbiome
 We demonstrate that the exposure was associated with an increase in gut microbial
diversity and indicated also that skin microbiome could be changed with a more 
intensive exposure to the material. 
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 In conclusion, nature-derived microbial exposure strategies have the potential to
modulate gut and skin microbiome and they could be further developed for trials testing 
their efficacy in the treatment and prevention of immune-mediated diseases. 
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Figures 
Figure 1. Study design and exposure. a. The study participants were interviewed and samples 
were taken before starting the exposure period (day 0), after the 2-week exposure period 
(day 14) and 3 weeks after the exposure period (day 35). b. The exposure group rubbed the 
exposure material in their palms 3 times per day during the exposure period (left). The hands 
were washed with water and dried in a paper towel after each treatment (right). c. A skin 
swab was taken from the center of volar surface of the forearm (red area). The hands were in 
direct contact with the exposure material (gray area). 
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Figure 2. Skin and gut bacterial community changes during the exposure period. a. The plots 
show proportional abundance of top 8 phyla between time points prior (Visit 1) and 
immediately after the 2-week exposure period (Visit 2) in the skin (upper panel) and gut 
(lower panel) of the exposure group subjects (Grp1-Grp7). Heavily exposed individuals (Grp3 
and Grp5) are marked with black frames. b. Rate of change in the Shannon α-diversity of the 
skin (black dots) and the gut (white dots) after the exposure period. Heavily exposed 
individuals (Grp3 and Grp5) are marked with red dots. Change in gut α-diversity is significantly 
higher in the exposure group than in the control group in unpaired t-test (p=0.029). c. Phylum 
composition of the exposure material. For each phylum, number of OTUs, total number of 
reads and average number of reads per OTU are shown. 
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SUPPLEMENTARY FIGURES 
Supplementary Figure 1. Bacterial community changes over time in control group skin and 
stool microbial composition. The plots show proportional abundance of top 8 phyla 
between time points prior (Visit 1) and immediately after (Visit 2) the 2-week exposure 
period in the skin (upper panel) and gut (lower panel) of the control group subjects (Grp1-
Grp7). The plots show proportional abundance of top 10 phyla, accounting for 99% of reads, 
between time points prior and after exposure for each control subject.  
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Supplementary Figure 2. QQ plots supporting Gaussian distribution. Shannon alpha 
diversity scores are plotted for skin (left) and stool (right) samples. With the exception of a 
few outliers, the distributions are normal. None of the data points were excluded from our 
statistical tests. 
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Exposure group Control group 
Overall model, N = 7 R2=0.971, p=0.001 R2=0.241, p=0.576 
p-value p-value 
(Constant) 0.194 0.088 
Skin alpha diversity change <0.0005 0.355 
Gut alpha diversity change 0.005 0.428 
Supplementary Figure 3. Multivariable linear regression with relative 
TFG-b expression after exposure as dependent variable. The change in 
skin and stool diversity is associated with the level of TGF-beta 
expression after the exposure period. The figure illustrates correlation 
between skin alpha diversity change and TGF-beta expression level in 
exposed (black dots) and controls (open dots). 
22 
SUPPLEMENTARY TABLES 
Supplementary Table 1. Exposure questionnaire. Exposure questionnaire indicates 
deviation from the soil treatment protocol for G3 and G5 and the longest duration of visible 
soil on the hands (yellow cells) 
Subject
Missed 
soil 
treatm
ents 
Instructed 
treatment 
time
Water 
wash 
after 
treatme
nt
Soap 
wash 
after 
treatm
ent
Skipped 
water 
wash 
after 
treatme
nt
Instructe
d water 
wash 
time (5 
sec)
Drying 
hands 
after 
water 
wash
Unpleasa
nt 
sensation
s from 
soil 
treatmen
t
Concrete negative 
effects from soil 
treatment
Difficulties 
performing soil 
treatment
Changes caused by 
soil treatment (hands 
and otherwise)?
Duration 
of 
changes 
reported 
in the 
previous 
question
G1
Yes, 
once
Yes Yes No No
Yes, 5-10 
sec.
on a 
towel
No No
Remembering 
to do it was 
sometimes 
difficult
No -
G2
Yes, 
once
Yes Yes No No Yes
on a 
paper 
towel
No
The soil spreads into 
the surroundings 
from the bucket, 
used a hand lotion 
more than normally 
just in case
it was difficult 
to remember all 
the washes.
Visible soil on the 
skin
Whole 
time 
between 
the soil 
treatment
s
G3 No Yes
Yes, but 
after 0,5 
week 
started 
to only 
rinse 
the 
hands 
with 
water
No No Yes
dabbed 
the 
hands 
on a 
paper 
towel 
(not 
really 
drying 
them)
No
Visible soil under 
the nails, the skin on 
the hands was more 
dry at first, soil 
stayed visibly in the 
folds of the skin on 
the fingers (did not 
rub the hands in the 
paper while drying 
them)
the soil spreads 
into the 
surroundings 
from the 
bucket, the 
bucket lid was 
hard to open, 
remembering to 
do it was 
difficult.
Visible soil under the 
nails, soil stayed 
visibly in the folds of 
the skin on the 
fingers, the skin on 
the hands was more 
dry but it got better 
after a while (used a 
hand lotion the 
whole period)
3-4 days
G4 No Yes Yes No No Yes
on a 
towel
No
the skin on the 
hands got more dry. 
Got a runny nose at 
the same time that 
started to use the 
soil, was wondering 
whether it was a 
coincidence
the soil spreads 
into the 
surroundings 
from the bucket
Visibe soil stains in 
the hands, visible soil 
under nails, it made 
the skin more dry 
than usual (hand 
lotion in use the 
whole time)
They 
dissapear
ed as soon 
as I 
stopped 
to use the 
soil
G5
Yes, 4 
times
Yes Yes No No
Yes, 5-10 
sec.
Mostly 
I didn't 
dry the 
hands
No
Hands left marks on 
surfaces (light 
switches etc.), the 
soil spreads into the 
surroundings from 
the bucket, visible 
soil under nails
It's hard to 
travel while 
performing the 
soil treatments
Soil under the nails about 24 h
G6
No, but 
I did it 
a bit 
later 
than in 
the 
schedu
le on 
few 
occatio
ns
Yes Yes No No Yes
on a 
paper 
towel
No
the skin on the 
hands got more dry 
(used a hand lotion 
1-2 x day)
Remembering 
to do it was 
sometimes 
difficult, the 
soil spreads into 
the 
surroundings 
from the 
bucket, the 
bucket lid was 
hard to open at 
first
Skin in the hands was 
more dry than usually
a couple 
of days
G7
Yes, 3 
times
Yes Yes No No Yes
rubbed 
them 
with 
paper 
towel
No
No (used hand 
lotion just in case)
Remembering 
to do it was 
sometimes 
difficult
No -
